Daniela Brunner, PhD is the Chief Innovation Officer of PsychoGenics inc. and founder of ScienceForward, which is focused on the development of digital health technology and treatments for rare disorders and underserved populations. She is part of the Business Advisory Board of the Children's Tumor Foundation, and serves as senior scientific advisor to various non-profit organizations, helping with the development of novel therapies. Dr. Brunner has worked on the validation of preclinical models of developmental, psychiatric and neurodegenerative disease models for the last 20 years. A major focus of her work has been the development of high throughput AI platforms for analysis of behavioral data, for preclinical and clinical R&D.